These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23834709)

  • 1. Evaluating the acute contributions of dopaminergic replacement to gait with obstacles in Parkinson's disease.
    Pieruccini-Faria F; Vitório R; Almeida QJ; Silveira CR; Caetano MJ; Stella F; Gobbi S; Gobbi LT
    J Mot Behav; 2013; 45(5):369-80. PubMed ID: 23834709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstacle crossing in people with Parkinson's disease: foot clearance and spatiotemporal deficits.
    Galna B; Murphy AT; Morris ME
    Hum Mov Sci; 2010 Oct; 29(5):843-52. PubMed ID: 19962206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
    Morris M; Iansek R; McGinley J; Matyas T; Huxham F
    Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Parkinson's disease and levodopa on adaptation of anticipatory postural adjustments.
    Hall LM; Brauer SG; Horak F; Hodges PW
    Neuroscience; 2013 Oct; 250():483-92. PubMed ID: 23867768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers.
    Burleigh-Jacobs A; Horak FB; Nutt JG; Obeso JA
    Mov Disord; 1997 Mar; 12(2):206-15. PubMed ID: 9087979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
    Pieruccini-Faria F; Jones JA; Almeida QJ
    Neuroscience; 2016 Mar; 318():219-29. PubMed ID: 26794593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor planning in Parkinson's disease patients experiencing freezing of gait: the influence of cognitive load when approaching obstacles.
    Pieruccini-Faria F; Jones JA; Almeida QJ
    Brain Cogn; 2014 Jun; 87():76-85. PubMed ID: 24727559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstacle crossing in Parkinson's disease: mediolateral sway of the centre of mass during level-ground walking and obstacle crossing.
    Galna B; Murphy AT; Morris ME
    Gait Posture; 2013 Sep; 38(4):790-4. PubMed ID: 23647655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Footstep adjustments used to turn during walking in Parkinson's disease.
    Huxham F; Baker R; Morris ME; Iansek R
    Mov Disord; 2008 Apr; 23(6):817-23. PubMed ID: 18200603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait analysis in patients with Parkinson's disease off dopaminergic therapy.
    Svehlík M; Zwick EB; Steinwender G; Linhart WE; Schwingenschuh P; Katschnig P; Ott E; Enzinger C
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1880-6. PubMed ID: 19887212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral coordination of walking and freezing of gait in Parkinson's disease.
    Plotnik M; Giladi N; Hausdorff JM
    Eur J Neurosci; 2008 Apr; 27(8):1999-2006. PubMed ID: 18412621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Step initiation in Parkinson's disease: influence of initial stance conditions.
    Rocchi L; Chiari L; Mancini M; Carlson-Kuhta P; Gross A; Horak FB
    Neurosci Lett; 2006 Oct; 406(1-2):128-32. PubMed ID: 16901637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of obstacle height on obstacle crossing in mild Parkinson's disease.
    Vitório R; Pieruccini-Faria F; Stella F; Gobbi S; Gobbi LT
    Gait Posture; 2010 Jan; 31(1):143-6. PubMed ID: 19854057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
    Vacherot F; Attarian S; Eusebio A; Azulay JP
    Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstacle Avoidance Increases Asymmetry of Crossing Step in Individuals With Parkinson's Disease and Neurologically Healthy Individuals.
    Barbieri FA; Simieli L; Orcioli-Silva D; Baptista AM; Borkowske Pestana M; Spiandor Beretta V; Dos Santos PCR; Bucken Gobbi LT
    J Mot Behav; 2018; 50(1):17-25. PubMed ID: 28632105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease.
    Almeida QJ; Frank JS; Roy EA; Patla AE; Jog MS
    Mov Disord; 2007 Sep; 22(12):1735-42. PubMed ID: 17557356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of visual feedback sampling on obstacle crossing behavior in people with Parkinson's disease.
    Vitório R; Lirani-Silva E; Barbieri FA; Raile V; Stella F; Gobbi LT
    Gait Posture; 2013 Jun; 38(2):330-4. PubMed ID: 23347768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular complexity during gait is not responsive to medication in persons with Parkinson's disease.
    Roemmich RT; Fregly BJ; Hass CJ
    Ann Biomed Eng; 2014 Sep; 42(9):1901-12. PubMed ID: 24866571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.